|1.||Anker, Stefan D: 7 articles (10/2015 - 12/2009)|
|2.||Ponikowski, Piotr: 7 articles (10/2015 - 12/2009)|
|3.||Bregman, David B: 7 articles (04/2014 - 01/2012)|
|4.||Gasche, Christoph: 6 articles (05/2015 - 05/2008)|
|5.||Mori, Claudio: 6 articles (03/2015 - 12/2009)|
|6.||Stein, Jürgen: 5 articles (05/2015 - 09/2011)|
|7.||Koch, Todd A: 5 articles (04/2014 - 01/2013)|
|8.||Butcher, Angelia: 5 articles (04/2014 - 01/2012)|
|9.||Gutzwiller, Florian S: 4 articles (10/2015 - 09/2011)|
|10.||Filippatos, Gerasimos: 4 articles (03/2015 - 12/2009)|
01/01/2015 - "Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women."
07/24/2014 - "[Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. "
04/01/2012 - "Intravenous ferric carboxymaltose accelerates erythropoietic recovery from experimental malarial anemia."
01/01/2012 - "Ferric carboxymaltose may represent a cost-saving option compared with the most likely alternative existing therapies used for the management of anemia in the National Health Service of Greece."
01/01/2014 - "FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized controlled trial."
12/01/2014 - "Recently published work (multicentric randomized controlled double-blinde trial) CONFIRM HF have proved that administration of ferric carboxymaltose in heart failure patients have improved their functional ability, NYHA stratification and quality of life. "
01/01/2014 - "Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea."
01/01/2015 - "Ferric carboxymaltose improved self-reported patient global assessment, New York Heart Association functional class and exercise capacity in patients with chronic heart failure and iron deficiency in two randomized, placebo-controlled trials (FAIR-HF and CONFIRM-HF). "
04/20/2010 - "Ferric carboxymaltose improved symptoms and quality of life in patients with chronic heart failure and iron deficiency."
10/01/2015 - "Patient characteristics and ferric carboxymaltose effectiveness (quality-adjusted life years) were taken from the Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure trial. "
|3.||Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/01/2012 - "Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials."
09/01/2013 - "Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients."
04/01/2014 - "Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial."
02/01/2014 - "A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia."
01/01/2010 - "Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications."
|4.||Kidney Diseases (Kidney Disease)
07/01/2015 - "The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study."
03/01/2009 - "The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject) on anaemia in a pre-dialysis population of chronic kidney disease patients."
01/01/2014 - "Studies of intravenous ferric carboxymaltose administration in the postpartum setting and in patients with non-dialysis-dependent chronic kidney disease revealed a decrease in serum phosphate levels that was generally asymptomatic and transient. "
01/01/2013 - "The aim of this study is to examine the effect of IV ferric carboxymaltose(FCM) on phosphate metabolism and FGF23 levels in patients with chronic kidney disease(CKD). "
09/01/2015 - "[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease]."
|5.||Uterine Hemorrhage (Uterine Bleeding)
12/01/2009 - "Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial."
12/01/2009 - "The objective was to evaluate efficacy and safety of rapid, large-dose intravenous (IV) administration of ferric carboxymaltose compared to oral iron in correcting iron deficiency anemia due to heavy uterine bleeding. "
12/01/2009 - "In patients with iron deficiency anemia due to heavy uterine bleeding, rapid IV administration of large doses of a new iron agent, ferric carboxymaltose, is more effective than oral iron therapy in correcting anemia, replenishing iron stores, and improving quality of life."
01/01/2009 - "Intravenously administered ferric carboxymaltose was effective in the treatment of iron-deficiency anaemia in several 6- to 12-week, randomized, open-label, controlled, multicentre trials in various patient populations, including those with inflammatory bowel disease, heavy uterine bleeding or postpartum iron-deficiency anaemia, and those with chronic kidney disease not undergoing or undergoing haemodialysis. "
01/01/2015 - "In other randomized controlled trials, ferric carboxymaltose replenished iron stores and corrected anaemia in various populations with iron-deficiency anaemia, including patients with chronic kidney disease, inflammatory bowel disease or heavy uterine bleeding, postpartum iron-deficiency anaemia and perioperative anaemia. "
|2.||saccharated ferric oxide
|3.||Drug Therapy (Chemotherapy)
|4.||Blood Transfusion (Blood Transfusions)